CXCR2 and Hepatic fibrosis: The study demonstrated that PPARα activation attenuated liver fibrosis by reducing the expression of pro-inflammatory cytokines and chemokines, including CXCR1 and CXCR2, thus highlighting the potential link between PPARα and CXCR1/2 in liver inflammation and fibrosis [44].